IP Verse

Adare Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Adare Pharmaceuticals, Inc. opposed by its competitors

Patent:
EP3041476
Grant Date:
Jan 25, 2023
Title:
Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis
Oppositions:
1
Patent:
EP2646003
Grant Date:
Jun 3, 2020
Title:
Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods
Oppositions:
1
Patent:
EP3403654
Grant Date:
Jul 31, 2019
Title:
Orally Administered Corticosteroid Compositions
Oppositions:
1
Patent:
EP2482822
Grant Date:
Aug 1, 2018
Title:
Orally Administered Corticosteroid Compositions
Oppositions:
1

Competitors of Adare Pharmaceuticals, Inc.

DR. FALK PHARMA GMBH

Want to track Adare Pharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you